Related Experiment Video

Updated: Jul 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin

A Kowala-Piaskowska1, W Słuzewski, M Figlerowicz

  • 1Dept. Infectious Diseases and Child Neurology, Karol Marcinkowski University of Medical Sciences, Szpitalna 27/33, 60-572 Poznan, Poland. arletakp1@wp.pl

Infection
|June 15, 2007
PubMed

Insights

In children with chronic hepatitis C (CHC), lower hepatitis C virus (HCV) RNA viral load positively influenced early virological response (EVR) to combination therapy. Other factors like HCV RNA in PBMCs and ALT levels did not significantly impact EVR.

Area of Science:

  • Hepatology
  • Virology
  • Pediatric Gastroenterology

Background:

  • Chronic hepatitis C virus (HCV) infection affects approximately 3% of the global population.
  • Combination therapy with pegylated interferon (IFN) alfa and ribavirin achieves HCV replication inhibition in 54-56% of adult patients.
  • Pediatric CHC treatment efficacy and prognostic factors require further investigation.

Purpose of the Study:

  • To investigate prognostic factors associated with early virological response (EVR) in children with CHC.
  • To evaluate the impact of baseline characteristics on treatment outcomes in pediatric CHC patients.
  • To analyze the relationship between viral load, HCV genotype, and treatment response.

Main Methods:

  • Twenty-three children with chronic HCV received combination therapy with peginterferon alfa-2a or alfa-2b and ribavirin.
  • Prognostic factors assessed included age, infection duration, HCV genotype, viral load, HCV RNA in PBMCs, ALT levels, and adherence.
  • EVR was defined as undetectable serum HCV RNA or a >2 log10 decrease from baseline after 12 weeks.

Main Results:

  • Early virological response (EVR) was achieved in 15 out of 23 patients (65.3%) after 12 weeks of therapy.
  • Lower baseline HCV RNA viral load was significantly associated with achieving EVR.
  • HCV RNA presence in PBMCs, lower ALT activity, and oncologic history did not influence EVR achievement.

Conclusions:

  • Lower baseline HCV RNA viral load is a positive predictor of EVR in children with CHC treated with peginterferon alfa and ribavirin.
  • HCV RNA levels in PBMCs and ALT activity do not appear to influence EVR in this pediatric cohort.
  • The influence of adherence on EVR in children with CHC remains unclear and warrants further study.
Abstract

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...